FOXI2 Activators
FOXI2 activators belong to a class of chemical compounds that specifically interact with and modulate the activity of the forkhead box I2 (FOXI2) transcription factor. The FOXI2 protein is part of the larger forkhead box family of transcription factors, which are characterized by a distinct DNA-binding domain known as the forkhead or winged-helix domain. These transcription factors play critical roles in the regulation of gene expression, influencing various cellular processes such as growth, proliferation, differentiation, and lifespan. The FOXI2 activators are designed to bind to this transcription factor, thereby affecting its ability to bind DNA and regulate gene expression. The exact mechanism of action of these activators can vary, but typically involves direct interaction with the FOXI2 protein, altering its conformation, and modulating its affinity for DNA and its transcriptional activity.
The chemical structure of FOXI2 activators is diverse, with various small molecules and peptides being identified that can function in this capacity. These compounds are often discovered through high-throughput screening methods, where large libraries of chemicals are tested for their ability to enhance the activity of FOXI2. The molecular design of FOXI2 activators frequently takes into consideration the structure of the forkhead domain of FOXI2, aiming to achieve specificity and high binding affinity. By directly influencing the activity of FOXI2, these activators can affect the expression of target genes under the control of this transcription factor. Given the importance of transcription factors in gene regulation, the study and development of FOXI2 activators can contribute significantly to the understanding of the fundamental mechanisms by which cellular function is controlled at the molecular level.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin increases intracellular cAMP levels, which can lead to activation of protein kinase A (PKA). PKA can then phosphorylate transcription factors that enhance the transcriptional activity of FOXI2, thus indirectly increasing its functional activity. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid acts as a ligand for retinoic acid receptors which can regulate gene expression. It can lead to the upregulation of FOXI2 by binding to retinoic acid response elements in the promoter region of the FOXI2 gene. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride inhibits glycogen synthase kinase-3 (GSK-3), which is known to modulate various transcription factors and could thus enhance FOXI2 activity by stabilizing transcriptional regulators that activate FOXI2 expression. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is known to inhibit DNA methyltransferases, which could decrease the methylation of the FOXI2 gene promoter, leading to increased expression and activity of FOXI2. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine is a DNA methyltransferase inhibitor that can cause hypomethylation of DNA and upregulation of genes. This can lead to an increase in FOXI2 expression if the FOXI2 gene promoter is demethylated. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is a histone deacetylase inhibitor which can enhance acetylation of histones, leading to a more open chromatin structure and potentially increased transcription of FOXI2. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate acts as a histone deacetylase inhibitor, which can lead to hyperacetylation of histones at the FOXI2 gene, enhancing its transcriptional activity. | ||||||
L-3,3′,5-Triiodothyronine, free acid | 6893-02-3 | sc-204035 sc-204035A sc-204035B | 10 mg 100 mg 250 mg | $41.00 $77.00 $153.00 | ||
T3 acts on thyroid hormone receptors that can regulate gene expression by binding to thyroid response elements. It can enhance FOXI2 activity by promoting transcriptional activation of genes regulated by FOXI2. | ||||||
β-Estradiol | 50-28-2 | sc-204431 sc-204431A | 500 mg 5 g | $63.00 $182.00 | 8 | |
17β-Estradiol binds to estrogen receptors which can alter gene transcription. It may enhance FOXI2 activity by upregulating transcription factors that increase FOXI2 expression. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, which may activate calcium-sensitive signaling pathways leading to enhanced transcriptional activity of FOXI2. | ||||||